These innovative therapies, including Semaglutide , belong to a group of drugs called GLP-1 agents. Originally approved for managing type 2 diabetes , they operate by encouraging the organism to release more insulin and curbing high sugar levels. Furthermore , their potential to encourage slimming has resulted to significant attention and widesp… Read More